NCT00117143
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
Not specified
Clinical trial condition
Thrombotic Microangiopathies
Explore clinical trials studying Thrombotic Microangiopathies. Study availability and eligibility vary by location and protocol.
396 public trials
101 recruiting studies
Thrombotic Microangiopathies trial results
NCT03275454
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
- Locations
-
- Georgetown Lombardi Comprehensive Cancer Center Georgetown, District of Columbia, United States
- Massachusetts General Hospital - Cancer Center Boston, Massachusetts, United States
- University of Pittsburgh Medical Center (UPMC) Hilman Cancer Center Pittsburgh, Pennsylvania, United States
- Essen University Hospital Department of Hematology Essen, Germany
NCT00937131
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
- Locations
-
- St Bartholomew's Hospital London, United Kingdom
- St Thomas Hosptial London, United Kingdom
- University College London Hospitals London, United Kingdom
NCT00713193
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +16 more
- Locations
-
- Ohio State University Columbus, Ohio, United States
Completed
Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
NCT02553317
- Conditions
- Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
- Locations
-
- Investigator Site Birmingham, Alabama, United States
- Investigator Site Los Angeles, California, United States
- Investigator Site Atlanta, Georgia, United States
- Investigator Site Boston, Massachusetts, United States
NCT01151423
- Conditions
- Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
- Locations
-
- Investigator Site Los Angeles, California, United States
- Investigator Site Washington D.C., District of Columbia, United States
- Investigator Site Atlanta, Georgia, United States
- Investigator Site St Louis, Missouri, United States
NCT01957176
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +23 more
- Locations
-
- Novartis Investigative Site Leuven, Belgium
- Novartis Investigative Site Shanghai, China
- Novartis Investigative Site Paris, France
- Novartis Investigative Site Athens, Greece
NCT03922308
- Conditions
- Acquired Thrombotic Thrombocytopenic Purpura (aTTP), Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- University of Minnesota Minneapolis, Minnesota, United States
- University Hospitals Cleveland Medical Center Cleveland, Ohio, United States
Completed
Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia
NCT05621330
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Qilu Hospital of Shandong University Shandong, China
NCT00508820
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +21 more
- Locations
-
Not specified